Arthur G. Lipman, Pharm.D. - International Association for Hospice ...

Arthur G. Lipman
Page 13
Editorials (continued)
Lipman AG. Hospital Formulary 1987;22.
97. Pain therapy: Time for a change, January, p. 13.
98. Drug samples in the hospital revisited, February, p. 123.
99. Biotechnology and the P&T committee, March, p. 221.
100. Managing the P&T committee agenda, April, p. 331.
101. The new drug diversion bill, May, p. 417.
102. State of the pharmaceutical industry, June, p. 509.
103. Physician dispensing: P&T committee implications, July, pp. 607, 610 (Weintraub M, Lipman AG).
104. Dealing with "me-too" drugs, August, p. 693.
105. The boom in home-use in-vitro diagnostics, September, p. 759.
106. Prescription drug poisonings and the P&T committee, October, p. 817
107. Pharmacist-conducted drug regimen review, November, p. 999.
108. A year end review of P&T committee accomplishments, December, p. 999.
Lipman AG. Hospital Formulary 1988;23
109. The paradox of therapeutic progress, January, p. 13.
110. The courage of our convictions, February, p. 117.
111. The FDA drug review process, March, p. 211.
112. JCAH to JCAHO: More than a change in name, April, p. 313.
113. Discharge medications and continuity of care, May, p. 410.
114. The impact of drug usage evaluations, June, p. 499.
115. Physicians' drug knowledge, July, p. 567 (Lipman AG, Weintraub, M).
116. Medication use by older Americans, August, p. 625.
117. The state of the pharmaceutical industry, September, p. 682.
118. The need for soft science, October, p. 769.
119. The case against multidisciplinary health care, November, p. 859.
120. Pharmacy dynamics, December, p. 948.
Lipman AG. J Pharm Care Pain Symptom Control. 1993;1.
121. Pharmaceutical care and symptom control, number 1, pp. 1-3.
122. Clinical guidelines for symptom control, number 2, pp. 1-4.
123. Perceptions of cancer pain and its treatment, number 3, pp. 1-4.
124. The stepped approach to cancer pain management, Number 4, pp. 1-3.
Lipman AG. J Pharm Care Pain Symptom Control. 1994;2.
125. The federal cancer pain guideline, Number 1, pp. 1-4.
126. The growth of interdisciplinary pain management is a double edged sword, Number 3, pp. 1-6
127. Practice policies in pain and symptom control, Number 4, pp. 1-4.
128. The editorial board. Number 1:1-4.
129. Are pharmacists barriers to cancer pain management Number 2:1-4
Lipman, AG. J Pharm Care Pain Symptom Control. 1996;4
130. A tribute to Robert Angarola. Number 3:1-2
131. Compounded Medications Can Compound Medication Problems. Number 4:1-3
Lipman, AG. J Pharm Care Pain Symptom Control. 1997:5
132. Must we make the courts our last resort Number 1:1-3
133. The reinventing of the agency for health care policy and research ahcpr. Number 2:1-4.
134. Opioids in chronic nonmalignant pain: the debate continues. Number 3: 1-2.
135. Symptom control: more than the management of pain. Number 4: 1-2.
Lipman, AG. J Pharm Care Pain Symptom Control. 1998;6
136. Managing the Information Explosion. Number 1:1-4
137. The Dilemma of Alternative Medicine. Number 2:1-4
138. Constipation Hurts. Number 3:1-3